TheraVasc Garners $172,501 New Funding Round

  • Feed Type
  • Date
    11/18/2013
  • Company Name
    TheraVasc
  • Mailing Address
    10000 Cedar Ave Cleveland, OH 44106
  • Company Description
    TheraVasc, Inc. is a privately-held biotechnology company with offices in Louisiana, focused on the development of novel vascular therapies with decreased risks through the repositioning of drugs with known safety profiles. The Company’s first program is ready to enter clinical trials for the treatment of peripheral artery disease (PAD).
  • Website
    http://www.theravasc.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $172,501
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.